• 1
    Hutterer F, Denk H, Bacchin PG, Schenkman JB, Schaffner F, Popper H. Mechanism of cholestasis. 2. Effect of bile acids on microsomal cytochrome P450-dependent biotransformation system in vivo. Life Sci 1970; 9:11591166.
  • 2
    Chen J, Farrell GC. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis. J Gastroenterol Hepatol 1996; 11:870877.MEDLINE
  • 3
    Chen J, Murray M, Jiang X-M, Liddle C, Farrell GC. Down-regulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats; importance to reduced hepatic content of cytochrome P450 cholestasis. Hepatology 1995; 22:580587.MEDLINE
  • 4
    Schaffner F, Bacchin PG, Hutterer F. Mechanism of cholestasis. 4. Structural and biochemical changes in the liver and serum in rats after bile duct-ligation. Gastroenterology 1971; 60:888897.MEDLINE
  • 5
    Kitani K, Kanai S, Ohta M, Tsukahara K. Ursodeoxycholate (UDC) prevents the hepatocellular damage caused by other bile salts as its conjugates in rats. Hepatology 1988; 8:14561460.
  • 6
    Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985; 248:G407G417.MEDLINE
  • 7
    Roda A, Piazza F, Baraldini M, Speroni E, Guerra MC, Cerrè C, Cantelli-Forti G. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. Hepatology 1998; 27:520525.MEDLINE
  • 8
    Kitani K, Kanai S, Sato Y, Ohta M. Tauro α-muricholate is as effective as Tauro β-muricholate and tauroursodeoxycholate in preventing the hepatocyte damage caused by continuous infusion of taurochenodeoxycholate in the rat. Hepatology 1994; 19:10111012.
  • 9
    Kitani K, Kanai S, Ohta M. The preventive effects of glycine conjugates of ursodeoxycholate, β-muricholate on taurochenodeoxycholate induced cholestasis in the rat. Acta Hepatol Jpn 1993; 34(suppl):247.
  • 10
    Roda A, Pellicciari R, Polimeni C, Cerré C, Cantelli Forti G, Sadeghpour B, Sapigni E, et al. Metabolism, pharmacockinetics, and activity of a new 6-fluoro analogue of ursodeoxycholic acid in rats and hamsters. Gastroenterology 1995; 108:12041214.MEDLINE
  • 11
    Gurantz D, Schteingart CD, Hagey LR, Steinbach JH, Grot T, Hofmann AF. Hypercholeresis induced by unconjugated bile acids infusion correlates with recovery in bile of unconjugated bile acids. Hepatology 1991; 13:340550.
  • 12
    Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, et al. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 1998; 273:1004610050.MEDLINE
  • 13
    Chianale J, Vollrath V, Wielandt AM, Amigo L, Rigotti A, Nervi F, Gonzalez S, et al. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J 1996; 314:781786.MEDLINE
  • 14
    Salphati L, Bernet LZ. Modulation of P-glycoprotein expression by cytochrome P450 inducers in male and female rat livers. Biochemical Pharmacol 1998; 55:387395.
  • 15
    Lan LB, Dalton JT, Schetz EG. Mdr1 limits CYP3A metabolism in vivo. Mol Pharmacol 2000; 58:863869.MEDLINE
  • 16
    Huang L, Wring SA, Woolley JL, Brouwer KR, Serabjit-Singh C, Polli JW. Induction of P-glycoprotein and cytochrome P4503A by HIV protease inhibitors. Drug Metab Dispos 2001; 29:754760.MEDLINE
  • 17
    Accatino L, Pizarro M, Solis N, Koenig CS, Vollrath V, Chianale J. Modulation of hepatic content and biliary excretion of P-glycoprotein in hepatocellular and obstructive cholestasis in rat. J Hepatol 1996; 25:349361.MEDLINE
  • 18
    Durr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steiner HC, Meier PJ, Fattinger K. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Pharmacokin Drug Disp 2000; 68:598604.
  • 19
    Wang R, Salem M, Yousef IM, Tuchweber B, Lam P, Childs SJ, Helgason CD, et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci U S A 2001; 98:20112016.MEDLINE
  • 20
    Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Pojer C, Zenz R, Lammert F, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001; 121:170183.MEDLINE
  • 21
    Paolini M, Pozzetti L, Piazza F, Cantelli-Forti G, Roda A. Bile acids structure and selective modulation of murine hepatic cytochrome P450-linked enzymes. Hepatology 1999; 30:730739.MEDLINE
  • 22
    Paolini M, Pozzetti L, Piazza F, Guerra MC, Speroni E, Cantelli-Forti G, Roda A. Mechanism for the prevention of cholestasis involving cytochrome P4503A overexpression. J Inv Med 2000; 48:4959.
  • 23
    Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330:13421347.MEDLINE
  • 24
    Paolini M, Mesirca R, Pozzetti L, Sapone A, Cantelli-Forti G. Induction of CYP 2B1 mediated pentoxyresorufin O-dealkylase activity in different species, sex, and tissue by prototype 2B1-inducers. Chem Biol Interact 1995; 95:127139.MEDLINE
  • 25
    Bauer C, Corsi C, Paolini M. Stability of microsomal monooxygenases in murine liver S9 fractions derived from phenobarbital and β-naphthoflavone induced animals under various long-term conditions of storage. Teratogen Carcin Mut 1994; 14:1322.
  • 26
    Amet Y, Berthou F, Menez JF. Simultaneous radiometric and fluorimetric detection of lauric acid metabolites using high-performance liquid chromatography following esterification with 4-bromomethyl-6,7-dimethoxycoumarin in human and rat liver microsomes. J Chromatogr B Biomed Sci Appl 1996; 681:233239.
  • 27
    Lowry OH, Rosenbrough HJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193:265275.
  • 28
    Bailey YL. Techniques in Protein Chemistry. Amsterdam: Elsevier 1967: 340341.
  • 29
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680685.MEDLINE
  • 30
    Box GEP, Hunter WG. Statistics for Experiments. New York: Wiley 1978: 8082.
  • 31
    Roda A, Cerré C, Simoni P, Polimeni C, Vaccari C, Pistillo A. Determination of free acid amidated bile acid by high-performance liquid chromatography with evaporative light-scattering mass detenction. J Lipid Res 1992; 33:13931402.MEDLINE
  • 32
    Roda A, Minutello A, Angelotti MA, Fini A. Bile acids structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC. J Lipid Res 1990; 31:14331443.MEDLINE
  • 33
    Roda A, Hofmann AF, Mysels KJ. The influence of bile salt structure on self-association in aqueous solutions. J Biol Chem 1983; 258:63626370.MEDLINE
  • 34
    Shimada T, Yamazake H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994; 270:414423.MEDLINE
  • 35
    Watkins PB, Wrighton SA, Schuetz FG, Molowa DT, Guzelian PS. Identification of glucocorticoid-inducible cytochromes P450 in the intestinal mucosa of rats and man. J Clin Invest 1987; 80:10291036.MEDLINE
  • 36
    Tanaka M, Nakura H, Tateishi T, Watanabe M, Nakaya S, Kumai T, Kobayashi S. Ursodeoxycholic acid prevents hepatic cytochrome P450 isoenzyme reduction in rats with deoxycholic acid-induced-liver injury. J Hepatol 1999; 31:263270.MEDLINE
  • 37
    Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. The function of GP170, the multidrug resistance gene product, in rat liver canalicular membrane vescicles. J Biol Chem 1989; 264:1169311698.MEDLINE
  • 38
    Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, et al. Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 2001; 276:3941139418.MEDLINE
  • 39
    Araya Z, Wikvall K. 6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes. Biochim Biophys Acta 1999; 1438:4754.MEDLINE
  • 40
    Gupta S, Todd Stravitz R, Pandak WM, Muller M, Reno Vlahcevic Z, Hylemon PB. Regulation of multidrug resistance 2 P-glycoprotein expression by bile salts in rats and in primary cultures of rat hepatocytes. Hepatology 2000; 32:341347.MEDLINE